Status:
COMPLETED
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention
Lead Sponsor:
Samsung Medical Center
Conditions:
Angioplasty, Transluminal, Percutaneous Coronary
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study to determine whether statin pretreatment decrease myocardial infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Eligibility Criteria
Inclusion
- Presence of chest pain for more than 30 minutes but less than 12 hours after symptom onset
- ST segment elevation more than 1 mm in two or more contiguous leads or presumably a new onset left bundle branch blockage
Exclusion
- Cardiogenic shock
- History of myocardial infarction
- Chronic liver disease
- Previous or current statin use
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT00610870
Start Date
July 1 2007
End Date
August 1 2009
Last Update
March 3 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710